|
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
|
5R01CA185251-04
|
$700,207
|
|
BEEBE, DAVID
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping
|
1R44CA210820-01A1
|
$989,401
|
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
|
5R01CA186338-03
|
$342,938
|
|
LI, MIN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Zinc Chemoprevention of Arsenic Co-Carcinogenesis
|
5R01CA182969-04
|
$314,363
|
|
HUDSON, LAURIE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
$2,495
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
$47,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
XLF in double-strand break repair and chemo/radiosensitization
|
5R01CA166264-05
|
$307,700
|
|
POVIRK, LAWRENCE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Workshop on Methods in Supportive Oncology Research
|
5R25CA181000-04
|
$309,257
|
|
TEMEL, JENNIFER
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
WNT4 IN ENDOCRINE RESPONSE AND RESISTANCE IN INVASIVE LOBULAR CARCINOMA
|
4R00CA193734-03
|
$249,000
|
|
SIKORA, MATTHEW
|
UNIVERSITY OF COLORADO DENVER
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
$10,856
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
|
1P50CA211024-01A1
|
$2,184,999
|
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
|
5R01CA210125-02
|
$656,491
|
|
WOODALL, W
|
KLEIN BUENDEL, INC.
|
|
Water Soluble Polymers to Target Tumor-Associated Extracellular Matrix for Delivery of MMP Inhibitors
|
1F31CA213901-01A1
|
$44,044
|
|
SUBRAHMANYAM, NITHYA
|
UNIVERSITY OF UTAH
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-04
|
$1,316,888
|
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE
|
1U24CA209837-01A1
|
$632,875
|
|
SHOGHI, KOORESH
|
WASHINGTON UNIVERSITY
|
|
Wake Forest NCORP Research Base
|
3UG1CA189824-04S1
|
$189,075
|
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Wake Forest NCORP Research Base
|
5UG1CA189824-04
|
$3,481,450
|
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer
|
5R01CA157372-06
|
$380,300
|
|
THAKUR, MATHEW
|
THOMAS JEFFERSON UNIVERSITY
|
|
Visualization and Epigenomic Characterization of Early Intestinal Tumorigenesis in Mice
|
1R01CA212374-01
|
$434,625
|
|
LAIRD, PETER
|
VAN ANDEL RESEARCH INSTITUTE
|
|
Viruses and Cancer
|
2T32CA060395-21A1
|
$224,723
|
|
MEYERS, CRAIG
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Viral Oncology Training Grant
|
5T32CA009111-39
|
$387,094
|
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-03
|
$332,363
|
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
VEGF signaling in Mammary Tumorigenesis
|
2R01CA168464-06
|
$397,813
|
|
MERCURIO, ARTHUR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Vascular communication in metastatic brain colonization
|
5R01CA184594-04
|
$321,625
|
|
KLEMKE, RICHARD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Varicella virus antigens in glioma etiology and survival
|
5U01CA182371-04
|
$552,893
|
|
WIEMELS, JOSEPH
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Vangl Dependent PCP Signaling Mediates EMT Induced Cell Invasiveness
|
5F31CA210467-02
|
$38,596
|
|
VANDERVORST, KACEY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Vanderbilt Training Program in Molecular and Genetic Epidemiology of Cancer
|
2T32CA160056-07
|
$403,151
|
|
SHU, XIAO-OU
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-05
|
$592,247
|
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of the Pre-BCR Signaling Complex in pre-B ALL Cell Model by Two-Color Single Particle Tracking and Peptidomimetic Inhibition
|
5F31CA192848-03
|
$8,966
|
|
ERASMUS, MICHAEL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Validation of Quantitative 11C-Erlotinib PET for Imaging EGFR-Mutant Lung Cancer
|
5R01CA195493-03
|
$255,891
|
|
MORRIS, EVAN
|
YALE UNIVERSITY
|
|
Validation of pancreatic cancer biomarkers in large prospective cohorts
|
5R01CA196286-03
|
$417,779
|
|
LOKSHIN, ANNA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation of Methylated Vimentin as a Diagnostic Test for Barrett's Esophagus
|
5UH2CA205105-02
|
$317,889
|
|
WILLIS, JOSEPH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Validation of Methylated Vimentin as a Diagnostic Test for Barrett's Esophagus
|
5UH2CA205105-02
|
$317,889
|
$317,889
|
WILLIS, JOSEPH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
5UH2CA206124-02
|
$248,101
|
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics
|
5R33CA177333-04
|
$298,354
|
|
FEDERSPIEL, MARK
|
MAYO CLINIC ROCHESTER
|
|
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
|
5R33CA196470-02
|
$390,115
|
|
LIN, QIAO
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Validating and Characterizing a New Melanoma Therapeutic Target
|
1R01CA217625-01
|
$646,803
|
|
COURTNEIDGE, SARA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
UW Radiological Sciences Training Program
|
5T32CA009206-39
|
$488,926
|
|
HALL, TIMOTHY
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-03S1
|
$50,000
|
$625
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-04
|
$700,000
|
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-04
|
$700,000
|
$8,750
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-04
|
$688,299
|
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-04
|
$688,299
|
$8,604
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using zebrafish to study the role of six1a/b and microRNA-30a in rhabdomyosarcoma (RMS) initiation and progression
|
5R21CA201809-02
|
$202,928
|
|
FORD, HEIDE
|
UNIVERSITY OF COLORADO DENVER
|
|
Using Text Messaging to Increase HPV Vaccination among Young Sexual Minority Men
|
5R21CA208329-02
|
$208,815
|
|
MUSTANSKI, BRIAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Using Technology to Scale-Up an Occupational Sun Protection Policy Program
|
1R01CA210259-01A1
|
$682,639
|
|
BULLER, DAVID
|
KLEIN BUENDEL, INC.
|
|
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
|
1R21CA216756-01
|
$187,050
|
|
SMALLEY, KEIRAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Using markers to improve pancreatic cancer screening and surveillance
|
5U01CA210170-02
|
$953,081
|
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
Total relevant funding to Esophagus for this search: $42,071,329
|